STOCK TITAN
  1. Home
  2. GRCL

Gracell Biotechnologies (GRCL) Stock Price, News & Analysis

GRCL NASDAQ

Company Description

Gracell Biotechnologies (NASDAQ: GRCL) is classified in the pharmaceutical preparation manufacturing industry within the Manufacturing sector.

This page collects what Stock Titan holds for GRCL, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

Latest News

View All
0.00%

Gracell Biotechnologies Acquisition Completed

acquisition
+1.04%

Gracell Biotechnologies Announces Shareholders’ Approval of Merger Agreement

acquisition
+1.19%

Gracell Biotechnologies Announces FDA Clearance of IND Application for Phase 1 Clinical Trial of FasTCAR-T GC012F as Early-Line Treatment of Multiple Myeloma

clinical trial fda approval
+60.26%

AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases

acquisition
+60.26%

Gracell Biotechnologies to be acquired by AstraZeneca, furthering cell therapy ambition across oncology and autoimmune diseases

acquisition
+5.79%

Gracell Biotechnologies Announces China NMPA Clearance for IND Application for Phase 1/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Refractory Systemic Lupus Erythematosus

clinical trial

Gracell Biotechnologies has 10 recent news articles. Of the recent coverage, 9 articles coincided with positive price movement and 0 with negative movement. Key topics include acquisition, clinical trial, fda approval, conferences, earnings. View all GRCL news →

SEC Filings

View All

No SEC filings available for GRCL.

Financial Highlights

—
Revenue (latest FY)
—
Net Income (latest FY)
—
Diluted EPS (latest FY)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

GRCL Company Profile & Sector Positioning

Gracell Biotechnologies (GRCL) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.